Use of a liquid allergy vaccine formulation for oromucosal administration

A liquid vaccine, oral mucosal technology, applied in the directions of allergen antigen components, medical preparations with non-active ingredients, drug combinations, etc. Simple effect of drug regimen

Inactive Publication Date: 2014-07-23
ALK ABELLO SA
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Second, transmission of the offending allergen occurs most frequently, resulting in allergic polyreactivity
However, such a pulse escalation therapy has a disadvantage: the occurrence of serious side effects cannot be ruled out and thus, like subcutaneous administration, it requires the supervision of an allergist specialist

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of a liquid allergy vaccine formulation for oromucosal administration
  • Use of a liquid allergy vaccine formulation for oromucosal administration
  • Use of a liquid allergy vaccine formulation for oromucosal administration

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Example 1: Sublingual immunotherapy (SLIT) without dose escalation ( ) - new treatment options

[0085] introduction

[0086] Over the past few years, several studies have been conducted using sublingual immunotherapy (SLIT) generating evidence of efficacy combined with a favorable safety profile (1).

[0087] In order for patients to obtain high levels of self-administered therapies such as effect, the compliance must be high (2). Given that the basis for compliance is convenience, it is relevant to enhance this property of the product. The excellent tolerability of SLIT has led to consideration of eliminating the possibility of increasing dose periods. This would improve patient convenience, which could increase compliance and potentially increase treatment efficiency. This study is designed to evaluate Tolerability in patients with mite or grass sensitization without dose escalation.

[0088] Materials and methods

[0089] potion

[0090] (ALK-Abell...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to the use of an allergen for the manufacture of a liquid vaccine formulation for preventing or treating allergy in a subject by oromucosal administration in a dosing regimen comprising no progressive dosage.

Description

[0001] This application is a divisional application of a Chinese invention patent application with a filing date of November 3, 2006, an application number of 200680045312.8, and an invention title of "Use of Liquid Allergic Vaccine Preparation for Oral Mucosal Administration". technical field [0002] The present invention relates to allergy vaccine formulations for oromucosal administration. Background of the invention [0003] Allergies are a serious health problem in countries adapted to a western lifestyle. Furthermore, the prevalence of allergic diseases is increasing in these countries. Although allergies are not generally considered a life-threatening disease, asthma is responsible for a significant number of deaths each year. The abnormal prevalence of approximately 30% among adolescents causes significant losses in quality of life, workdays and money, thereby becoming a class of serious health problems in Western countries. [0004] Allergies are complex diseases...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/35A61K39/36A61K9/00A61K47/10A61K47/18A61K47/20A61K47/36A61P37/08
CPCA61K9/006A61K47/02A61K47/10
Inventor D·B·赫尔南德兹F·D·L·T·玛丁内兹P·R·涅图
Owner ALK ABELLO SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap